$BCBP
BCB BANCORP INC

2021 Form 10-K Financial Statement

#000122845422000020 Filed on March 09, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $112.6M $28.34M $113.4M
YoY Change -0.75% -8.5% -8.2%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.000M $800.0K $3.000M
YoY Change 0.0% 0.0% 3.45%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $15.18M $5.584M $33.02M
YoY Change -54.02% -48.72% -19.38%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $48.26M $10.20M $29.42M
YoY Change 64.01% 39.52% -3.03%
Income Tax $14.02M $2.904M $8.566M
% Of Pretax Income 29.05% 28.47% 29.11%
Net Earnings $34.24M $7.298M $20.86M
YoY Change 64.17% 42.43% -0.84%
Net Earnings / Revenue 30.42% 25.76% 18.39%
Basic Earnings Per Share $1.94 $0.41 $1.14
Diluted Earnings Per Share $1.92 $0.41 $1.14
COMMON SHARES
Basic Shares Outstanding 17.06M 17.08M 17.21M
Diluted Shares Outstanding 17.24M 17.23M

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $261.2M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $24.70M $15.27M $30.30M
YoY Change -18.48% -23.33% -8.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $25.20M $17.72M $17.70M
YoY Change 42.37% 608.68% 608.0%
Other Assets $13.00M $12.60M $12.60M
YoY Change 3.17% 12.5% 12.5%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $2.968B $2.821B $2.821B
YoY Change 5.19% -2.97% -2.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $12.80M $15.20M $15.20M
YoY Change -15.79% -43.28% -43.28%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.80M $15.20M $15.20M
YoY Change -15.79% -43.28% -43.28%
LONG-TERM LIABILITIES
Long-Term Debt $37.30M $37.00M $37.00M
YoY Change 0.81% 0.54% 0.54%
Other Long-Term Liabilities $10.40M $10.30M $10.30M
YoY Change 0.97% -402.94% -402.94%
Total Long-Term Liabilities $47.70M $47.30M $47.30M
YoY Change 0.85% 41.62% 41.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.80M $15.20M $15.20M
Total Long-Term Liabilities $47.70M $47.30M $47.30M
Total Liabilities $2.694B $2.572B $2.572B
YoY Change 4.73% -3.61% -3.61%
SHAREHOLDERS EQUITY
Retained Earnings $58.34M
YoY Change 20.45%
Common Stock $192.3M
YoY Change 1.04%
Preferred Stock $25.72M
YoY Change 2.83%
Treasury Stock (at cost) $26.92M
YoY Change 22.09%
Treasury Stock Shares $2.467M
Shareholders Equity $274.0M $249.2M $249.2M
YoY Change
Total Liabilities & Shareholders Equity $2.968B $2.821B $2.821B
YoY Change 5.19% -2.97% -2.98%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income $34.24M $7.298M $20.86M
YoY Change 64.17% 42.43% -0.84%
Depreciation, Depletion And Amortization $3.000M $800.0K $3.000M
YoY Change 0.0% 0.0% 3.45%
Cash From Operating Activities $45.89M $132.7M $139.3M
YoY Change -67.07% 1326.88% 474.22%
INVESTING ACTIVITIES
Capital Expenditures $325.0K -$100.0K $1.388M
YoY Change -76.59% -66.67% -44.77%
Acquisitions
YoY Change
Other Investing Activities -$7.300M -$8.100M -$314.1M
YoY Change -97.68% -109.41% -328.27%
Cash From Investing Activities -$7.668M -$8.200M -$315.5M
YoY Change -97.57% -109.57% -333.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $3.729M $4.513M
YoY Change -17.37% -76.39%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 112.2M -23.90M -113.0M
YoY Change -199.29% -130.37% -157.72%
NET CHANGE
Cash From Operating Activities 45.89M 132.7M 139.3M
Cash From Investing Activities -7.668M -8.200M -315.5M
Cash From Financing Activities 112.2M -23.90M -113.0M
Net Change In Cash 150.4M 100.6M -289.1M
YoY Change -152.02% -42.08% -181.42%
FREE CASH FLOW
Cash From Operating Activities $45.89M $132.7M $139.3M
Capital Expenditures $325.0K -$100.0K $1.388M
Free Cash Flow $45.57M $132.8M $138.0M
YoY Change -66.97% 1283.33% 534.17%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001228454
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
CY2021 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
000-50275
CY2021 dei Entity Registrant Name
EntityRegistrantName
BCB BANCORP, INC.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NJ
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-0065262
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
104-110 Avenue C
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Bayonne
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07002
CY2021 dei City Area Code
CityAreaCode
800
CY2021 dei Local Phone Number
LocalPhoneNumber
680-6872
CY2021 dei Security12b Title
Security12bTitle
Common Stock, no par value
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Trading Symbol
TradingSymbol
BCBP
CY2021 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
203800000
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16984538
CY2021 dei Auditor Name
AuditorName
Wolf & Company, P.C
CY2021 dei Auditor Firm
AuditorFirmId
392
CY2021 dei Auditor Location
AuditorLocation
Boston, Massachusetts
CY2021Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
9606000
CY2020Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
23201000
CY2021Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
402023000
CY2020Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
238028000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
411629000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
261229000
CY2021Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2020Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
735000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
85186000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
99756000
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
25187000
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
17717000
CY2021Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
952000
CY2020Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
3530000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
37119000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
33639000
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2304942000
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2295021000
CY2021Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
6084000
CY2020Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
11324000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12237000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15272000
CY2021Q4 us-gaap Interest Receivable
InterestReceivable
9183000
CY2020Q4 us-gaap Interest Receivable
InterestReceivable
12924000
CY2021Q4 us-gaap Other Real Estate
OtherRealEstate
75000
CY2020Q4 us-gaap Other Real Estate
OtherRealEstate
414000
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12959000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
12574000
CY2021Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5431000
CY2020Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
5488000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12457000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14988000
CY2021Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
72485000
CY2020Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
61033000
CY2021Q4 us-gaap Other Assets
OtherAssets
7986000
CY2020Q4 us-gaap Other Assets
OtherAssets
9011000
CY2021Q4 us-gaap Assets
Assets
2967528000
CY2020Q4 us-gaap Assets
Assets
2821016000
CY2021Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
588207000
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
402100000
CY2021Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
1973195000
CY2020Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
1915950000
CY2021Q4 us-gaap Deposits
Deposits
2561402000
CY2020Q4 us-gaap Deposits
Deposits
2318050000
CY2021Q4 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
71711000
CY2020Q4 us-gaap Federal Home Loan Bank Advances Branch Of Fhlb Bank Amount Of Advances By Branch
FederalHomeLoanBankAdvancesBranchOfFHLBBankAmountOfAdvancesByBranch
191161000
CY2021Q4 us-gaap Subordinated Debt
SubordinatedDebt
37275000
CY2020Q4 us-gaap Subordinated Debt
SubordinatedDebt
37042000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
12752000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
15224000
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
10364000
CY2020Q4 us-gaap Other Liabilities
OtherLiabilities
10328000
CY2021Q4 us-gaap Liabilities
Liabilities
2693504000
CY2020Q4 us-gaap Liabilities
Liabilities
2571805000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2916
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2916
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2596
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2596
CY2021Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
28923000
CY2020Q4 us-gaap Additional Paid In Capital Preferred Stock
AdditionalPaidInCapitalPreferredStock
25723000
CY2020Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19708375
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19574858
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16940133
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17107640
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
193927000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
192276000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
81171000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
58335000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1128000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-205000
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2768242
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2467218
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
31125000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
26918000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
274024000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
249211000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2967528000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2821016000
CY2021 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
107660000
CY2020 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
107153000
CY2021 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
680000
CY2020 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
1748000
CY2021 us-gaap Interest Income Other
InterestIncomeOther
3274000
CY2020 us-gaap Interest Income Other
InterestIncomeOther
1690000
CY2021 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
959000
CY2020 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
2835000
CY2021 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
112573000
CY2020 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
113426000
CY2021 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
4335000
CY2020 us-gaap Interest Expense Demand Deposit Accounts
InterestExpenseDemandDepositAccounts
6147000
CY2021 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
505000
CY2020 us-gaap Interest Expense Savings Deposits
InterestExpenseSavingsDeposits
440000
CY2021 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
6160000
CY2020 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
19360000
CY2021 us-gaap Interest Expense Deposits
InterestExpenseDeposits
11000000
CY2020 us-gaap Interest Expense Deposits
InterestExpenseDeposits
25947000
CY2021 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
4180000
CY2020 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
7069000
CY2021 us-gaap Interest Expense
InterestExpense
15180000
CY2020 us-gaap Interest Expense
InterestExpense
33016000
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
97393000
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
80410000
CY2021 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
3855000
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
9441000
CY2021 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
93538000
CY2020 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
70969000
CY2021 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
3972000
CY2020 us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
2948000
CY2021 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
2952000
CY2020 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1033000
CY2021 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
667000
CY2020 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
892000
CY2021 bcbp Gain Loss On Sale Of Impaired Loans Held In Portfolio
GainLossOnSaleOfImpairedLoansHeldInPortfolio
-64000
CY2020 bcbp Gain Loss On Sale Of Impaired Loans Held In Portfolio
GainLossOnSaleOfImpairedLoansHeldInPortfolio
26000
CY2021 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
11000
CY2020 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-38000
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
371000
CY2020 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4378000
CY2020 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
964000
CY2021 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
147000
CY2020 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
1790000
CY2021 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
639000
CY2020 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
497000
CY2021 us-gaap Noninterest Income
NoninterestIncome
8695000
CY2020 us-gaap Noninterest Income
NoninterestIncome
12490000
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
26410000
CY2020 us-gaap Labor And Related Expense
LaborAndRelatedExpense
25916000
CY2021 us-gaap Occupancy Net
OccupancyNet
11360000
CY2020 us-gaap Occupancy Net
OccupancyNet
11748000
CY2021 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
6024000
CY2020 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
5676000
CY2021 us-gaap Professional Fees
ProfessionalFees
1919000
CY2020 us-gaap Professional Fees
ProfessionalFees
1682000
CY2021 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
1043000
CY2020 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
1548000
CY2021 bcbp Regulatory Assessments
RegulatoryAssessments
1310000
CY2020 bcbp Regulatory Assessments
RegulatoryAssessments
1344000
CY2021 us-gaap Advertising Expense
AdvertisingExpense
554000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
933000
CY2021 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
35000
CY2020 us-gaap Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
101000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1597000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1150000
CY2021 us-gaap Other Noninterest Expense
OtherNoninterestExpense
3723000
CY2020 us-gaap Other Noninterest Expense
OtherNoninterestExpense
3938000
CY2021 us-gaap Noninterest Expense
NoninterestExpense
53975000
CY2020 us-gaap Noninterest Expense
NoninterestExpense
54036000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
48258000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29423000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14018000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8566000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
34240000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
20857000
CY2021 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1160000
CY2020 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1300000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
33080000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19557000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.94
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.14
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.92
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17063000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17210000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17239000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17226000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
34240000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
20857000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-242000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
4299000
CY2020 bcbp Reclassification Adjustment For Gains Realized In Income
ReclassificationAdjustmentForGainsRealizedInIncome
964000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-242000
CY2020 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
3335000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-60000
CY2020 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
826000
CY2021 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-182000
CY2020 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2509000
CY2021 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
-2165000
CY2020 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
704000
CY2021 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
650000
CY2020 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
-208000
CY2021 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
1515000
CY2020 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
-496000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1333000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2013000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
35573000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
22870000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
239473000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
20857000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2013000
CY2020 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
126000
CY2020 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
10485000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11192000
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
500
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1194000
CY2020 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1300000
CY2020 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.56
CY2020 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
9225000
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
483000
CY2020 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
500000
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4870000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
249211000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
34240000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1333000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3200000
CY2021 bcbp Stock Issued During Period Shares Stock Option Exercised Excluding Cashless Exercises
StockIssuedDuringPeriodSharesStockOptionExercisedExcludingCashlessExercises
39291
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
287000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
417000
CY2021 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1160000
CY2021Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
CY2021Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.14
CY2021Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2021Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.16
CY2021 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
9775000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
478000
CY2021 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
301024
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4207000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
274024000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
34240000
CY2020 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
32730000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
20857000
CY2021 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2989000
CY2020 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2995000
CY2021 bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
767000
CY2020 bcbp Amortization And Accretion Net
AmortizationAndAccretionNet
2553000
CY2021 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
3855000
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
9441000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-975000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2013000
CY2021 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
26159000
CY2020 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
25917000
CY2021 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
29404000
CY2020 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
24196000
CY2020 bcbp Cares Act Proceeds From Sale Of Paycheck Protection Plan Loans
CaresActProceedsFromSaleOfPaycheckProtectionPlanLoans
124549000
CY2021 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
667000
CY2020 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
892000
CY2021 us-gaap Other Real Estate Valuation Adjustments
OtherRealEstateValuationAdjustments
-6000
CY2020 us-gaap Other Real Estate Valuation Adjustments
OtherRealEstateValuationAdjustments
-293000
CY2020 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
964000
CY2021 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
371000
CY2020 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
4378000
CY2021 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
147000
CY2020 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
1790000
CY2021 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
11000
CY2020 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-38000
CY2021 bcbp Gain Loss On Sale Of Impaired Loans Held In Portfolio
GainLossOnSaleOfImpairedLoansHeldInPortfolio
-64000
CY2020 bcbp Gain Loss On Sale Of Impaired Loans Held In Portfolio
GainLossOnSaleOfImpairedLoansHeldInPortfolio
26000
CY2021 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
2952000
CY2020 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
1033000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
417000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
1194000
CY2021 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-3741000
CY2020 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
4606000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1025000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-272000
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-412000
CY2020 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-1245000
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2613000
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
927000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
45893000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
139345000
CY2021 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
32597000
CY2021 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
26141000
CY2020 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
77098000
CY2020 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
26601000
CY2021 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
742000
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7419000
CY2021 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
8500000
CY2020 us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
60000000
CY2021 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
425000
CY2020 us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
878000
CY2021 bcbp Proceeds From Sale Of Impaired Loans
ProceedsFromSaleOfImpairedLoans
3442000
CY2020 bcbp Proceeds From Sale Of Impaired Loans
ProceedsFromSaleOfImpairedLoans
1416000
CY2020 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
48360000
CY2021 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
15148000
CY2020 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
200186000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
325000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1388000
CY2021 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
-5240000
CY2020 us-gaap Payments For Proceeds From Federal Home Loan Bank Stock
PaymentsForProceedsFromFederalHomeLoanBankStock
-2497000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7668000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-315491000
CY2021 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
243352000
CY2020 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-44013000
CY2021 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
10000000
CY2020 us-gaap Proceeds From Federal Home Loan Bank Borrowings
ProceedsFromFederalHomeLoanBankBorrowings
88161000
CY2021 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
130000000
CY2020 us-gaap Repayments Of Federal Home Loan Bank Borrowings
RepaymentsOfFederalHomeLoanBankBorrowings
142800000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4207000
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4870000
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
9775000
CY2020 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
9225000
CY2021 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1160000
CY2020 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1300000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
478000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
357000
CY2021 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
3200000
CY2020 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
11192000
CY2020 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
10485000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
287000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
112175000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-112978000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
150400000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-289124000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
261229000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
550353000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
411629000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
261229000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12020000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12652000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
15592000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
34262000
CY2021 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
81000
CY2021 bcbp Number Of Locations
NumberOfLocations
29
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentration of Risk Financial instruments which potentially subject the Company and its subsidiaries to concentrations of credit risk consist of cash and cash equivalents, investment and mortgage-backed securities and loans. Cash and cash equivalents include amounts placed with highly rated financial institutions. Securities include securities backed by the U.S. Government and other highly rated instruments. The Bank’s lending activity is primarily concentrated in loans collateralized by real estate in the State of New Jersey and the New York metropolitan area as a result, credit risk related to loans is broadly dependent on the real estate market and general economic conditions in the area.
CY2021Q4 bcbp Other Real Estate Owned Number Of Properties
OtherRealEstateOwnedNumberOfProperties
1
CY2021Q4 us-gaap Other Real Estate
OtherRealEstate
75000
CY2020Q4 us-gaap Other Real Estate
OtherRealEstate
414000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3588
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2021 us-gaap Net Income Loss
NetIncomeLoss
34240000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
20857000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
33080000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17063000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.94
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
19557000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17210000
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.14
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
176000
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
16000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
33080000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17239000
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.92
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
19557000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17226000
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
CY2021 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Reclassification Certain amounts as of and for the year ended December 31, 2020 have been reclassified to conform to the current year’s presentation. These changes had no effect on the Company’s consolidated results of operations or financial position.
CY2021Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
25200000
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
17700000
CY2021 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
147000
CY2020 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
1790000
CY2020 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
40000
CY2021 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
147000
CY2020 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
1750000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3027000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
82746000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
587000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
85186000
CY2020Q4 bcbp Available For Sale Securities Debt Maturities Within One Year Gross Unrealized Gains
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGains
97074000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2822000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
140000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
99756000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
20125000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
318000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
4681000
CY2021Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
269000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
24806000
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
587000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
11613000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
73000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
1278000
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
67000
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
12891000
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
140000
CY2021Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2343937000
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2330018000
CY2021Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
1876000
CY2021Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
15972000
CY2020Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
16063000
CY2021 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
5
CY2021 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
3487000
CY2021 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
3384000
CY2020 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
9
CY2020 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
1205000
CY2020Q4 us-gaap Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
1358000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
37119000
CY2020Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
33639000
CY2021Q4 bcbp Total Deductions From Gross Loans
TotalDeductionsFromGrossLoans
38995000
CY2020Q4 bcbp Total Deductions From Gross Loans
TotalDeductionsFromGrossLoans
34997000
CY2021Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2304942000
CY2020Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
2295021000
CY2021Q4 bcbp Participation Interest In Loans Originated
ParticipationInterestInLoansOriginated
196300000
CY2020Q4 bcbp Participation Interest In Loans Originated
ParticipationInterestInLoansOriginated
242600000
CY2021Q4 bcbp Acquired Loans Unpaid Principal Balance
AcquiredLoansUnpaidPrincipalBalance
140969000
CY2020Q4 bcbp Acquired Loans Unpaid Principal Balance
AcquiredLoansUnpaidPrincipalBalance
179601000
CY2021Q4 bcbp Acquired Loans Recorded Investment
AcquiredLoansRecordedInvestment
122533000
CY2020Q4 bcbp Acquired Loans Recorded Investment
AcquiredLoansRecordedInvestment
152556000
CY2020Q4 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
1078000
CY2019Q4 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
1681000
CY2021 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion
293000
CY2020 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion
603000
CY2021Q4 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
785000
CY2020Q4 us-gaap Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield
CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
1078000
CY2020 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield Reclassifications From Nonaccretable Difference
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYieldReclassificationsFromNonaccretableDifference
0
CY2021 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Accretable Yield Reclassifications From Nonaccretable Difference
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAccretableYieldReclassificationsFromNonaccretableDifference
0
CY2020Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
29159000
CY2019Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
33771000
CY2021 us-gaap Loans And Leases Receivable Related Parties Additions
LoansAndLeasesReceivableRelatedPartiesAdditions
14875000
CY2021 us-gaap Loans And Leases Receivable Related Parties Proceeds
LoansAndLeasesReceivableRelatedPartiesProceeds
12338000
CY2020 us-gaap Loans And Leases Receivable Related Parties Proceeds
LoansAndLeasesReceivableRelatedPartiesProceeds
4612000
CY2021Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
31696000
CY2020Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
29159000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33639000
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
472000
CY2021 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
97000
CY2021 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
3855000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
37119000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
7828000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
29291000
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
37119000
CY2021 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
1300000
CY2020 us-gaap Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans
LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans
1500000
CY2021 bcbp Nonaccrual Loans Interest Income Cash Basis Method
NonaccrualLoansInterestIncomeCashBasisMethod
1200000
CY2020 bcbp Nonaccrual Loans Interest Income Cash Basis Method
NonaccrualLoansInterestIncomeCashBasisMethod
710000
CY2021Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
3100000
CY2020Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
333000
CY2021Q4 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Acquired During Period At Acquisition At Fair Value
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAcquiredDuringPeriodAtAcquisitionAtFairValue
668000000000
CY2020Q4 us-gaap Certain Loans Acquired In Transfer Accounted For As Debt Securities Acquired During Period At Acquisition At Fair Value
CertainLoansAcquiredInTransferAccountedForAsDebtSecuritiesAcquiredDuringPeriodAtAcquisitionAtFairValue
1100000
CY2021Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
49382000
CY2021Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2294555000
CY2021Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2343937000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
23734000
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
42000
CY2020 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
506000
CY2020 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
9441000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33639000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
4461000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
29178000
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
33639000
CY2020Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
83201000
CY2020Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
2246817000
CY2020Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
2330018000
CY2021Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
14889000
CY2020Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
16396000
CY2021Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
26758000
CY2021Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
33085000
CY2020Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
68610000
CY2020Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
82212000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
22624000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
37191000
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
7828000
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
14591000
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
20722000
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
4461000
CY2021Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
49382000
CY2021Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
70276000
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
7828000
CY2020Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
83201000
CY2020Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
102934000
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
4461000
CY2021 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
35721000
CY2021 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
1480000
CY2020 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
31599000
CY2020 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
1266000
CY2021 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
23747000
CY2021 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
786000
CY2020 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
9497000
CY2020 us-gaap Impaired Financing Receivable With Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
429000
CY2021 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
59468000
CY2021 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
2266000
CY2020 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
41096000
CY2020 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
1695000
CY2020 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
1128000
CY2021 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
0
CY2020 us-gaap Financing Receivable Modifications Subsequent Default Recorded Investment1
FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1
216000
CY2020 us-gaap Financing Receivable Modifications Subsequent Default Number Of Contracts1
FinancingReceivableModificationsSubsequentDefaultNumberOfContracts1
1
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
2343937000
CY2021Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
3124000
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
2330018000
CY2020Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
333000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
29636000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35529000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17399000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20257000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12237000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15272000
CY2021 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2989000
CY2020 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2995000
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
4599000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
4254000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3296000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2423000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2032000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1613000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1399000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3062000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13825000
CY2021Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
9183000
CY2020Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
12924000
CY2021Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
588207000
CY2020Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
402100000
CY2021Q4 bcbp Demand Deposit Accounts Interest Bearing
DemandDepositAccountsInterestBearing
668262000
CY2020Q4 bcbp Demand Deposit Accounts Interest Bearing
DemandDepositAccountsInterestBearing
613882000
CY2021Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
337126000
CY2020Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
315208000
CY2021Q4 us-gaap Demand Deposit Accounts
DemandDepositAccounts
1593595000
CY2020Q4 us-gaap Demand Deposit Accounts
DemandDepositAccounts
1331190000
CY2021Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
329724000
CY2020Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
297765000
CY2021Q4 us-gaap Time Deposits
TimeDeposits
638083000
CY2020Q4 us-gaap Time Deposits
TimeDeposits
689095000
CY2021Q4 us-gaap Deposits
Deposits
2561402000
CY2020Q4 us-gaap Deposits
Deposits
2318050000
CY2021Q4 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
275000000.0
CY2020Q4 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
302900000
CY2021Q4 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
15900000
CY2021Q4 us-gaap Time Deposit Maturities Year One
TimeDepositMaturitiesYearOne
569231000
CY2021Q4 us-gaap Time Deposit Maturities Year Two
TimeDepositMaturitiesYearTwo
44113000
CY2021Q4 us-gaap Time Deposit Maturities Year Three
TimeDepositMaturitiesYearThree
16312000
CY2021Q4 us-gaap Time Deposit Maturities Year Four
TimeDepositMaturitiesYearFour
5836000
CY2021Q4 us-gaap Time Deposit Maturities After Year Five
TimeDepositMaturitiesAfterYearFive
2591000
CY2021Q4 us-gaap Time Deposits
TimeDeposits
638083000
CY2020Q4 us-gaap Deposits Received For Securities Loaned At Carrying Value
DepositsReceivedForSecuritiesLoanedAtCarryingValue
20000000.0
CY2021 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
48000
CY2020 us-gaap Shortterm Debt Average Outstanding Amount
ShorttermDebtAverageOutstandingAmount
160000
CY2020 us-gaap Shortterm Debt Maximum Monthend Outstanding Amount
ShorttermDebtMaximumMonthendOutstandingAmount
25000000
CY2021Q4 bcbp Short Term Debt Average Interest Rate
ShortTermDebtAverageInterestRate
0.0050
CY2020Q4 bcbp Short Term Debt Average Interest Rate
ShortTermDebtAverageInterestRate
0.0036
CY2021Q4 us-gaap Federal Home Loan Bank Advances Weighted Average Interest Rate
FederalHomeLoanBankAdvancesWeightedAverageInterestRate
0.0139
CY2021Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
71711000
CY2020Q4 us-gaap Federal Home Loan Bank Advances Weighted Average Interest Rate
FederalHomeLoanBankAdvancesWeightedAverageInterestRate
0.0166
CY2020Q4 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
191161000
CY2021 bcbp Federal Home Loan Bank Advances Unamortized Prepayment Penalties
FederalHomeLoanBankAdvancesUnamortizedPrepaymentPenalties
2100000
CY2020 bcbp Federal Home Loan Bank Advances Unamortized Prepayment Penalties
FederalHomeLoanBankAdvancesUnamortizedPrepaymentPenalties
2600000
CY2021Q4 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
733300000
CY2020Q4 us-gaap Loans Pledged As Collateral
LoansPledgedAsCollateral
814600000
CY2019Q4 us-gaap Debt Securities Trading Restricted
DebtSecuritiesTradingRestricted
0
CY2020Q4 us-gaap Debt Securities Trading Restricted
DebtSecuritiesTradingRestricted
0
CY2021 bcbp Maximum Ratio Of Debt To Total Assets Under Debt Covenant
MaximumRatioOfDebtToTotalAssetsUnderDebtCovenant
0.500
CY2021Q4 bcbp Maximum Total Debt Under Debt Covenant
MaximumTotalDebtUnderDebtCovenant
1484000000
CY2021 bcbp Maximum Ratio Of Debt To Total Assets Under Debt Covenant
MaximumRatioOfDebtToTotalAssetsUnderDebtCovenant
0.500
CY2021Q4 us-gaap Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses After Tax
DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
-912000
CY2020Q4 us-gaap Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses After Tax
DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesAfterTax
-3095000
CY2021 bcbp Estimated Long Term Inflation Rate
EstimatedLongTermInflationRate
0.030
CY2021Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Next Twelve Months
DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
450000
CY2021Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Two
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
432000
CY2021Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Three
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
413000
CY2021Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Four
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
414000
CY2021Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Year Five
DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
409000
CY2021Q4 us-gaap Defined Benefit Plan Expected Future Benefit Payments Five Fiscal Years Thereafter
DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
1912000
CY2021 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
230000
CY2020 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
558000
CY2021 us-gaap Restricted Stock Expense
RestrictedStockExpense
187000
CY2020 us-gaap Restricted Stock Expense
RestrictedStockExpense
636000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
417000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
1194000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
22304
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
12.46
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
26700
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
12.89
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
22304
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
12.46
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
26700
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
12.89
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1200975
CY2019 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.93
CY2019 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.32
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.45
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y18D
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2806000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
8127
CY2020 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Forfeited Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsForfeitedExercisePriceRangeLowerRangeLimit
11.26
CY2020 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Forfeited Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsForfeitedExercisePriceRangeUpperRangeLimit
12.46
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.68
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
500
CY2020 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Exercised Exercise Price Range
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsExercisedExercisePriceRange
10.55
CY2020 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Exercised Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsExercisedExercisePriceRangeLowerRangeLimit
10.55
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
10.55
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1192348
CY2020 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
8.93
CY2020 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.32
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.45
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y14D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
333000
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
70723
CY2021 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Exercised Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsExercisedExercisePriceRangeLowerRangeLimit
8.93
CY2021 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Exercised Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsExercisedExercisePriceRangeUpperRangeLimit
12.46
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.87
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
72800
CY2021 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Granted Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsGrantedExercisePriceRangeLowerRangeLimit
12.89
CY2021 bcbp Share Based Compensation Shares Authorized Under Stock Option Plan Options Granted Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlanOptionsGrantedExercisePriceRangeUpperRangeLimit
13.68
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.96
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1194425
CY2021 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
9.02
CY2021 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
13.68
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.64
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y5M8D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4528000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
860625
CY2021 bcbp Stock Issued During Period Shares Cashless Stock Options Exercised
StockIssuedDuringPeriodSharesCashlessStockOptionsExercised
31432
CY2021Q4 bcbp Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Underlying Unexercised Options
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnderlyingUnexercisedOptions
333800
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
573000
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P4Y6M
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y1M13D
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0086
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2840
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0432
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.04
CY2021Q4 bcbp Minimum Percentage Of Capital Stock Surplus Under Dividend Restriction
MinimumPercentageOfCapitalStockSurplusUnderDividendRestriction
0.50
CY2021 us-gaap Cash Dividends Paid To Parent Company
CashDividendsPaidToParentCompany
15885000
CY2020 us-gaap Cash Dividends Paid To Parent Company
CashDividendsPaidToParentCompany
18212000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
8736000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
6407000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
6257000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
4172000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
14993000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
10579000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-571000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1122000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-404000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-891000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-975000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2013000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14018000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8566000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
10610000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
8884000
CY2021Q4 bcbp Deferred Income Tax Assets Other Real Estate Owned Expenses
DeferredIncomeTaxAssetsOtherRealEstateOwnedExpenses
11000
CY2020Q4 bcbp Deferred Income Tax Assets Other Real Estate Owned Expenses
DeferredIncomeTaxAssetsOtherRealEstateOwnedExpenses
9000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
361000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
755000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
234000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
884000
CY2021Q4 bcbp Deferred Income Tax Assets Valuation Adjustment On Loans Receivable Acquired
DeferredIncomeTaxAssetsValuationAdjustmentOnLoansReceivableAcquired
1277000
CY2020Q4 bcbp Deferred Income Tax Assets Valuation Adjustment On Loans Receivable Acquired
DeferredIncomeTaxAssetsValuationAdjustmentOnLoansReceivableAcquired
1810000
CY2021Q4 bcbp Deferred Tax Assets Operating Loss Carryforwards Net Of Valuation Adjustment
DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAdjustment
1359000
CY2020Q4 bcbp Deferred Tax Assets Operating Loss Carryforwards Net Of Valuation Adjustment
DeferredTaxAssetsOperatingLossCarryforwardsNetOfValuationAdjustment
1455000
CY2021Q4 bcbp Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
3645000
CY2020Q4 bcbp Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
4352000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1509000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1178000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
19006000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
19327000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
77000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
145000
CY2021Q4 bcbp Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
3561000
CY2020Q4 bcbp Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
4284000
CY2021Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
1028000
CY2020Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
1088000
CY2021Q4 bcbp Deferred Income Tax Liabilities Sba Servicing Asset
DeferredIncomeTaxLiabilitiesSbaServicingAsset
520000
CY2020Q4 bcbp Deferred Income Tax Liabilities Sba Servicing Asset
DeferredIncomeTaxLiabilitiesSbaServicingAsset
688000
CY2021Q4 bcbp Deferred Income Tax Liabilities Borrowing Modification
DeferredIncomeTaxLiabilitiesBorrowingModification
597000
CY2021Q4 bcbp Deferred Income Tax Liabilities Defined Benefit Plans
DeferredIncomeTaxLiabilitiesDefinedBenefitPlans
264000
CY2020Q4 bcbp Deferred Income Tax Liabilities Defined Benefit Plans
DeferredIncomeTaxLiabilitiesDefinedBenefitPlans
548000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6047000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6753000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
12959000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
12574000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
12574000
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
11180000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-975000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2013000
CY2021 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
-60000
CY2020 us-gaap Other Comprehensive Income Availableforsale Securities Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
827000
CY2021 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-650000
CY2020 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
208000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
12959000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
12574000
CY2018Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
8700000
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
6500000
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
6900000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
10134000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
6179000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
4684000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2592000
CY2021 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
45000
CY2020 us-gaap Income Tax Reconciliation Tax Exempt Income
IncomeTaxReconciliationTaxExemptIncome
99000
CY2021 bcbp Income Tax Reconciliation Bank Owned Life Insurance Income
IncomeTaxReconciliationBankOwnedLifeInsuranceIncome
620000
CY2020 bcbp Income Tax Reconciliation Bank Owned Life Insurance Income
IncomeTaxReconciliationBankOwnedLifeInsuranceIncome
217000
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-135000
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
111000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14018000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8566000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.290
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.291
CY2021Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
269675000
CY2020Q4 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
253516000
CY2021 bcbp Number Of Operating Leases
NumberOfOperatingLeases
29
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
3711000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
976000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12457000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3296000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10529000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1073000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
12752000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y11M26D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0260
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3296000
CY2021Q4 bcbp Lessee Operating Lease Liability Payments Year One To Year Three
LesseeOperatingLeaseLiabilityPaymentsYearOneToYearThree
4455000
CY2021Q4 bcbp Lessee Operating Lease Liability Payments Year Three To Year Five
LesseeOperatingLeaseLiabilityPaymentsYearThreeToYearFive
3012000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
3062000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
13825000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1073000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
12752000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
85186000
CY2021Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
25187000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
110373000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
99756000
CY2020Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
17717000
CY2020Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
117473000
CY2021Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
22624000
CY2020Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
14591000
CY2021Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
7828000
CY2020Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
4461000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1128000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-205000

Files In Submission

Name View Source Status
0001228454-22-000020-index-headers.html Edgar Link pending
0001228454-22-000020-index.html Edgar Link pending
0001228454-22-000020.txt Edgar Link pending
0001228454-22-000020-xbrl.zip Edgar Link pending
bcbp-20211231.xsd Edgar Link pending
bcbp-20211231x10k.htm Edgar Link pending
bcbp-20211231x10kg001.jpg Edgar Link pending
bcbp-20211231x10k_htm.xml Edgar Link completed
bcbp-20211231xex10_11.htm Edgar Link pending
bcbp-20211231xex10_12.htm Edgar Link pending
bcbp-20211231xex10_13.htm Edgar Link pending
bcbp-20211231xex21.htm Edgar Link pending
bcbp-20211231xex23.htm Edgar Link pending
bcbp-20211231xex31_1.htm Edgar Link pending
bcbp-20211231xex31_2.htm Edgar Link pending
bcbp-20211231xex32.htm Edgar Link pending
bcbp-20211231xex3_1.htm Edgar Link pending
bcbp-20211231_cal.xml Edgar Link unprocessable
bcbp-20211231_def.xml Edgar Link unprocessable
bcbp-20211231_lab.xml Edgar Link unprocessable
bcbp-20211231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending